Literature DB >> 23885326

Role of toll-like receptors in multiple sclerosis.

Socorro Miranda-Hernandez1, Alan G Baxter.   

Abstract

Multiple Sclerosis (MS) is an autoimmune disease in which Central Nervous System (CNS) lesions result from perivascular immune cell infiltration associated with damage to myelin, oligodendrocytes and neurons. CNS autoimmunity and its regulation are dominated by the inflammatory cytokines IL17 and IFNγ, and the opposing regulatory cytokines IL10 and the type I IFNs. Toll-like receptors (TLR) play a critical role in modulating cytokine and chemokine secretion in response to exogenous Pathogen Associated to Molecular Patterns and endogenous Danger-Associated to Molecular Patterns. Here, we systematically examine the evidence that TLR play a major role in the initiation disease, the triggering of relapses, and regulation of CNS damage. Data from human studies are supported analyses of a variety of animal models, including Experimental Autoimmune Encephalomyelitis in TLR-deficient mice.

Entities:  

Keywords:  Multiple sclerosis; TLR1; TLR10; TLR2; TLR3; TLR4; TLR5; TLR6; TLR7; TLR8; TLR9; autoimmunity; gene/environment interactions; hygiene hypothesis; microbial flora; toll-like receptors

Year:  2013        PMID: 23885326      PMCID: PMC3714200     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  151 in total

1.  The risk of relapses in multiple sclerosis during systemic infections.

Authors:  Jorge Correale; Marcela Fiol; Wendy Gilmore
Journal:  Neurology       Date:  2006-07-26       Impact factor: 9.910

2.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.

Authors:  F Re; J L Strominger
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.

Authors:  A Stefferl; U Brehm; M Storch; D Lambracht-Washington; C Bourquin; K Wonigeit; H Lassmann; C Linington
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

5.  Relapsing central and peripheral demyelinating diseases. Unusual pathologic features.

Authors:  S M de la Monte; A H Ropper; G R Dickersin; N L Harris; J A Ferry; E P Richardson
Journal:  Arch Neurol       Date:  1986-06

6.  Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production.

Authors:  Chiaki Fujimoto; Cheng-Rong Yu; Guangpu Shi; Barbara P Vistica; Eric F Wawrousek; Dennis M Klinman; Chi-Chao Chan; Charles E Egwuagu; Igal Gery
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

7.  Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10.

Authors:  S Thoma-Uszynski; S M Kiertscher; M T Ochoa; D A Bouis; M V Norgard; K Miyake; P J Godowski; M D Roth; R L Modlin
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.

Authors:  Konstantin E Balashov; Latt Latt Aung; Adi Vaknin-Dembinsky; Suhayl Dhib-Jalbut; Howard L Weiner
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

9.  Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Authors:  Asa Andersson; Ruxandra Covacu; Dan Sunnemark; Alexandre I Danilov; Assunta Dal Bianco; Mohsen Khademi; Erik Wallström; Anna Lobell; Lou Brundin; Hans Lassmann; Robert A Harris
Journal:  J Leukoc Biol       Date:  2008-07-21       Impact factor: 4.962

10.  Central nervous system Toll-like receptor expression in response to Theiler's murine encephalomyelitis virus-induced demyelination disease in resistant and susceptible mouse strains.

Authors:  Nicolas P Turrin
Journal:  Virol J       Date:  2008-12-18       Impact factor: 4.099

View more
  36 in total

Review 1.  Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections.

Authors:  Borros Arneth
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

Review 2.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

3.  Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts.

Authors:  Manabu Watanabe; Mai Kasai; Hideyuki Tomizawa; Masamitsu Aoki; Kazuo Eiho; Yoshiaki Isobe; Shigehiro Asano
Journal:  ACS Med Chem Lett       Date:  2014-10-02       Impact factor: 4.345

4.  Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Ana Cristina Wing; Taissa M Kasahara; Priscila M Sacramento; Solange Camargo; Fernanda Rueda; Soniza V Alves-Leon; Regina Alvarenga; Claudia Cristina Vasconcelos; Anshu Agrawal; Sudhir Gupta; Cleonice A M Bento
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

5.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

6.  Association between toll-like receptor 6 expression and auxiliary T cells in the peripheral blood of pediatric patients with allergic purpura.

Authors:  Hong Chang; Yongxian Cao; Y I Lin; Haiyan Zhu; Yuan Fu; Xiuxia Chen; Qiuye Zhang
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

7.  Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis.

Authors:  Alyria Teixeira Dias; Sandra Bertelli Ribeiro de Castro; Caio César de Souza Alves; Marcilene Gomes Evangelista; Luan Cristian da Silva; Daniele Ribeiro de Lima Reis; Marco Antonio Machado; Maria Aparecida Juliano; Ana Paula Ferreira
Journal:  Inflamm Res       Date:  2018-04-23       Impact factor: 4.575

8.  Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.

Authors:  Kelly D McCall; Jean R Thuma; Maria C Courreges; Fabian Benencia; Calvin B L James; Ramiro Malgor; Noriko Kantake; William Mudd; Nathan Denlinger; Bret Nolan; Li Wen; Frank L Schwartz
Journal:  Endocrinology       Date:  2014-11-25       Impact factor: 4.736

Review 9.  Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.

Authors:  Akbar Mohammad Hosseini; Jafar Majidi; Behzad Baradaran; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-12-31

Review 10.  Microglial Phenotypes and Functions in Multiple Sclerosis.

Authors:  Elaine O'Loughlin; Charlotte Madore; Hans Lassmann; Oleg Butovsky
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.